Tuesday, 17 July 2018

Give your Potential talk on Adolescent Medicine

Adolescent medicine otherwise known as hebiatrics is concerned with the care of patients who are in adolescent period of development. The field of adolescent medicine tends to the necessities of the entire individual from an assortment of mental; sociological; and physiological perspective. Issues of medical ethics are particularly related to confidentiality and the privilege to consent for therapeutic care are pertinent to the practice of adolescent medicine.
To know more, PS: https://goo.gl/7zAJFy

Monday, 16 July 2018

Doctors Using Virtual Reality to Ease Needle Phobias in Children

Virtual Reality (VR) incorporates mainly auditory and visual, an interactive computer- generated experience taking place within a simulated environment. Current VR technology most commonly uses virtual reality headsets or multi-projected environments that simulate a user's physical presence in a virtual or imaginary environment.For children, getting injections can be traumatic, with the fear making what would probably be only a brief scratch into something much worse. Doctors started using VR as a means to ease fears and make trips to get those injections less likely to end in trauma.
To know more, PS:  https://goo.gl/x6YWyX

Monday, 9 July 2018

Oral Presentation on Lethal Perinatal Hypophosphatasia

Mark your calendars!! We are delighted to announce that #DrLauraCastells will be presenting her talk under the session #Neonatology & #Perinatology at #Pediatrics2018 scheduled on October 22-23, 2018 in #Vienna, #Austria.  Avail the great opportunity to meet eminent #speakers from all over the world!! To know more, PS: https://goo.gl/x6YWyX

Friday, 6 July 2018

Get to know about Cystic Hygroma!!

Cystic hygromas are fluid-filled sacs that occur mostly on the head or neck of a baby as a result of blockages in the lymphatic system. It can be detected using ultrasounds during pregnancy and can also be diagnosed after the baby is born. It affect 1 in 800 pregnancies and 1 in 8,000 live births.
In 80% of cases, cystic hygromas appear on the face, including the head, neck, mouth, cheek, or tongue & the growths can also occur in other areas of the body, including the armpits, chest, legs, buttocks, and groin. Cystic hygromas causes are unknown, but genetic abnormalities are present in about 25% to 75% of affected children & the disease is more common in individuals with Down Syndrome.

Cystic hygromas that are present at birth or develop after birth are usually benign, meaning they are not harmful. Symptoms and signs vary with the location of the cluster of cysts and include the appearance of cluster of cysts that are sometimes visible with the naked eye and may cause breathing difficulties, feeding problems, sleep apnea, & failure to thrive. Some additional tests to diagnose Cystic Hygroma includes Transvaginal ultrasound, Fast Spin Magnetic Resonance Imaging, Amniocentesis, etc. It might not need treatment if it is not causing any problems. Usually cystic hygromas are diagnosed when the fetus is still in the womb, often during a routine abdominal ultrasound and may also detect it during a blood test carried out at 15 to 20 weeks & if the blood test shows high levels of alpha-fetoproteins, it might include a possible cystic hygroma.

Thursday, 5 July 2018

New Technology in NICU predicts the risk of life-threatening infections

Infection is the leading cause of death in this fragile patient population and a new technology called HeRO-Heart Rate Observation System in the NICU predicts the risk of life-threatening infections upto 24 hours before they appear in severely premature or critically ill infants.
HeRO uses an algorithm to detect slight changes in a baby's heartbeat that could be an early sign of a major infection, like sepsis which is a bacterial infection that is highly dangerous to babies born three pounds or less.

HeRO system uses a 0-7 surveillance score generated after a heart rate is analyzed, with anything higher than a two considered an alert for possible infection. This kind of monitoring system represents part of the next generation of technology to save lives and help achieve the ultimate goal to provide the highest quality of comprehensive and compassionate care to NICU babies so they can thrive and go home with their families as soon as possible.
To know more, PS: https://goo.gl/x6YWyX

Monday, 2 July 2018

Cancer Caused by inhaling Nitric Oxide?

Nitric Oxide is a highly reactive gas, and nitrogen oxides have long been recognized as toxic environmental pollutants and the Inhaled Nitric Oxide use in the neonatal period is associated with an increased risk of neonatal cancers, and specifically liver tumours as a new potential risk factor.
 & it is a pulmonary vasodilator that is used to treat conditions associated with reversible vasoconstriction & pulmonary hypertension. It plays a major role in regulating vascular muscle tone & has emerged as a treatment for hypoxemic respiratory failure in newly born infants associated with persistent high pulmonary vascular pressure.

Recent research indicated that inhaled Nitric Oxide can be applied in various diseases & studies suggested that inhaled Nitric Oxide is a safe and effective agent to determine the vasodilatory capacity of the pulmonary vascular bed. Clinical Applications of Inhaled NO include Pulmonary Hypertension of the newborn, Preventing Chronic Lung Disease in the Newborn, Safety and Cost-Effectiveness of Inhaled NO in the Newborn. Inhaled NO is the first vasodilator to produce truly selective pulmonary vasodilation & large number of laboratory and clinical research studies have been performed to delineate the biochemistry, physiology. side effects, and clinical efficacy of inhaled NO in various diseases of children and adults. The clinical use of inhaled NO has become widespread.The birth database that the authors used included just over 1 million births between 2000 and 2011, with the outcome of interest being malignant disease diagnosed at any time, so the average follow up was about 6.5 years. There were just over 1000 cancers diagnosed, so about 0.1% of live born babies. 2.2% of the total birth cohort of babies were in the NICU database, whereas nearly 6% of the cancers were among NICU patients.
To know more, PS: https://goo.gl/x6YWyX

Saturday, 30 June 2018

Keynote Speech on Sensory Processing Disorder

We are glad to announce that Dr. Bariah Dardari will be presenting a Keynote Speech under the Session #Pediatrics.
Join Us at Pediatrics 2018 Conference held at Vienna, Austria during October 22-23, 2018 focusing on the theme Channelizing Modern Techniques to improve Neonatal and Pediatrics Health
Grab the Great Opportunity to meet Renowned Speakers all over the world and Discuss about the advancements in the Pediatrics and Neonatal field.
Only Limited Slots Available!!! Book your Slots at the earliest!! PS: https://bit.ly/2rsV0Za